CELC
Celcuity Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.
Market Cap: 440 Million
Primary Exchange: NASDAQ
Website: celcuity.com
Shares Outstanding: 24.2 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.49458884628035765
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Ethical Flags
Longest drawdown: 1158 trading days
From: 2018-09-20 To: 2021-06-25
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|